Stocks traded mostly lower on Friday after President Donald Trump followed through on his pledge to enact tariffs on Mexico ...

Vertex Pharmaceuticals announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene ...

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...

Snowflake might acquire startup Redpanada, a data analytics software startup, that could boost the cloud company’s AI and ...

Learn more about whether Natera, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on AAII's A+ ...

Vertex (VERX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

As Chief Technology Officer, Sal leads the company’s technology strategy, software engineering and innovation roadmap to accelerate growth. He joined Vertex in 2021 after 30 years of technology and ...

This collaboration is set to revolutionize the industrial mobile communications landscape by introducing intrinsically safe ...

Vertex AI RAG Engine streamlines the complex process of retrieving relevant information from a knowledge base and feeding it to an LLM, Google said. Google has formally introduced Vertex AI RAG ...

Get Wall Street's Hottest Chart Every Morning RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients who ...